Company profile
TamoRx company profile
TamoRx’s founding inventors have discovered a novel biological mechanism within cells that restricts the immune system from fighting cancer. The research team is focused on developing a new therapy that frees patients’ immune systems from this restriction to increase immune attack on cancer cells within tumours offering a new hope for a broad range of cancer patients. TamoRx aims to develop small molecule inhibitors that work both as a single agent and in combination with other treatments, increasing the applicability of immunotherapy for patients.
Business identity
- Operating status
- Active
- Company type
- For Profit
- Founded
- 2016-01-01, Year
Headquarters
- Headquarters
- Sandnes, Rogaland, Norway
- Postal code
- 1010
- Country code
- NO
- Continent
- Europe